137 related articles for article (PubMed ID: 2858349)
1. Avarol, a cytostatically active compound from the marine sponge Dysidea avara.
Müller WE; Zahn RK; Gasić MJ; Dogović N; Maidhof A; Becker C; Diehl-Seifert B; Eich E
Comp Biochem Physiol C Comp Pharmacol Toxicol; 1985; 80(1):47-52. PubMed ID: 2858349
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of mitosis by avarol, a natural product isolated from the sponge Dysidea avara.
Müller WE; Dogovic N; Zahn RK; Maidhof A; Diehl-Seifert B; Becker C; Sachsse W; Gasic MJ; Schröder HC
Basic Appl Histochem; 1985; 29(4):321-30. PubMed ID: 4096684
[TBL] [Abstract][Full Text] [Related]
3. A new bioactive derivative of avarol from the marine sponge Dysidea avara.
Crispino A; de Giulio A; de Rosa S; Strazzullo G
J Nat Prod; 1989; 52(3):646-8. PubMed ID: 2778453
[TBL] [Abstract][Full Text] [Related]
4. Antimicrobial activity of avarol, a sesquiterpenoid hydroquinone from the marine sponge, Dysidea avara.
Cariello L; Zanetti L; Cuomo V; Vanzanella F
Comp Biochem Physiol B; 1982; 71(2):281-3. PubMed ID: 6800687
[No Abstract] [Full Text] [Related]
5. Sponge secondary metabolites: biochemical and ultrastructural localization of the antimitotic agent avarol in Dysidea avara.
Müller WE; Diehl-Seifert B; Sobel C; Bechtold A; Kljajić Z; Dorn A
J Histochem Cytochem; 1986 Dec; 34(12):1687-90. PubMed ID: 3782777
[TBL] [Abstract][Full Text] [Related]
6. Isolation of sesquiterpenoids from sponge Dysidea avara and chemical modification of avarol as potential antitumor agents.
Shen YC; Lu CH; Chakraborty R; Kuo YH
Nat Prod Res; 2003 Apr; 17(2):83-9. PubMed ID: 12713119
[TBL] [Abstract][Full Text] [Related]
7. Application of cell culture for the production of bioactive compounds from sponges: synthesis of avarol by primmorphs from Dysidea avara.
Müller WE; Böhm M; Batel R; De Rosa S; Tommonaro G; Müller IM; Schröder HC
J Nat Prod; 2000 Aug; 63(8):1077-81. PubMed ID: 10978201
[TBL] [Abstract][Full Text] [Related]
8. In vitro evaluation of cytotoxic and mutagenic activity of avarol.
Pejin B; Iodice C; Kojic V; Jakimov D; Lazovic M; Tommonaro G
Nat Prod Res; 2016 Jun; 30(11):1293-6. PubMed ID: 26181496
[TBL] [Abstract][Full Text] [Related]
9. Developmental aberrations in sea-urchin eggs induced by avarol and two cogeners, the main sesquiterpenoid hydroquinones from the marine sponge, Dysidea avara.
Cariello L; De Nicola Giudici M; Zanetti L
Comp Biochem Physiol C Comp Pharmacol; 1980; 65C(1):37-41. PubMed ID: 6102012
[No Abstract] [Full Text] [Related]
10. In vitro avarol does affect the growth of Candida sp.
Pejin B; Ciric A; Markovic D; Tommonaro G; Sokovic M
Nat Prod Res; 2016 Sep; 30(17):1956-60. PubMed ID: 26405848
[TBL] [Abstract][Full Text] [Related]
11. New avarone and avarol derivatives from the marine sponge Dysidea cinerea.
Hirsch S; Rudi A; Kashman Y; Loya Y
J Nat Prod; 1991; 54(1):92-7. PubMed ID: 1710654
[TBL] [Abstract][Full Text] [Related]
12. Liposomal integration method for assessing antioxidative activity of water insoluble compounds towards biologically relevant free radicals: example of avarol.
Nakarada Đ; Pejin B; Tommonaro G; Mojović M
J Liposome Res; 2020 Sep; 30(3):218-226. PubMed ID: 31146614
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of In Vitro Cytotoxic Potential of Avarol towards Human Cancer Cell Lines and In Vivo Antitumor Activity in Solid Tumor Models.
Stanojkovic TP; Filimonova M; Grozdanic N; Petovic S; Shitova A; Soldatova O; Filimonov A; Vladic J; Shegay P; Kaprin A; Ivanov S; Nikitovic M
Molecules; 2022 Dec; 27(24):. PubMed ID: 36558184
[TBL] [Abstract][Full Text] [Related]
14. Avarol derivatives as competitive AChE inhibitors, non hepatotoxic and neuroprotective agents for Alzheimer's disease.
Tommonaro G; García-Font N; Vitale RM; Pejin B; Iodice C; Cañadas S; Marco-Contelles J; Oset-Gasque MJ
Eur J Med Chem; 2016 Oct; 122():326-338. PubMed ID: 27376495
[TBL] [Abstract][Full Text] [Related]
15. A new bioactive sesquiterpenoid quinone from the Mediterranean Sea marine sponge Dysidea avara.
Hamed AN; Wätjen W; Schmitz R; Chovolou Y; Edrada-Ebel R; Youssef DT; Kamel MS; Proksch P
Nat Prod Commun; 2013 Mar; 8(3):289-92. PubMed ID: 23678793
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of the activity of the sponge metabolites avarol and avarone and their synthetic derivatives against fouling micro- and macroorganisms.
Tsoukatou M; Maréchal JP; Hellio C; Novaković I; Tufegdzic S; Sladić D; Gasić MJ; Clare AS; Vagias C; Roussis V
Molecules; 2007 May; 12(5):1022-34. PubMed ID: 17873837
[TBL] [Abstract][Full Text] [Related]
17. Identification of avarol derivatives as potential antipsoriatic drugs using an in vitro model for keratinocyte growth and differentiation.
Amigó M; Schalkwijk J; Olthuis D; De Rosa S; Payá M; Terencio MC; Lamme E
Life Sci; 2006 Nov; 79(25):2395-404. PubMed ID: 16973179
[TBL] [Abstract][Full Text] [Related]
18. Further in vitro biological activity evaluation of amino-, thio- and ester-derivatives of avarol.
Tommonaro G; Pejin B; Iodice C; Tafuto A; De Rosa S
J Enzyme Inhib Med Chem; 2015 Apr; 30(2):333-5. PubMed ID: 24939096
[TBL] [Abstract][Full Text] [Related]
19. Further in vitro biological activity evaluation of amino-, thio- and ester-derivatives of avarol.
Tommonaro G; Pejin B; Iodice C; Tafuto A; De Rosa S
J Enzyme Inhib Med Chem; 2016 Aug; 31(4):684-6. PubMed ID: 26114310
[TBL] [Abstract][Full Text] [Related]
20. Avarol-induced DNA strand breakage in vitro and in Friend erythroleukemia cells.
Müller WE; Sladić D; Zahn RK; Bässler KH; Dogović N; Gerner H; Gasić MJ; Schröder HC
Cancer Res; 1987 Dec; 47(24 Pt 1):6565-71. PubMed ID: 2824036
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
